<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have shown increased immunoreactivity for neuropeptide Y (NPY) within the perilesional cortex following experimental middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) or focal excitotoxic damage </plain></SENT>
<SENT sid="1" pm="."><plain>Downregulation of the NPY Y1 receptor gene using an antisense oligodeoxynucleotide produced a doubling of the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, implying that NPY may mediate neuroprotection against focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of treatment with NPY on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and hemodynamic parameters were investigated in the present study </plain></SENT>
<SENT sid="3" pm="."><plain>Adult male Sprague-Dawley rats were anesthetized with <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> to undergo right-sided endovascular MCAO for 2 h </plain></SENT>
<SENT sid="4" pm="."><plain>A single dose of NPY was given via intracarotid injection (10 microg/kg) at the beginning of reperfusion, intracisternal injection (10 or 30 microg/kg) at 30 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, or intracerebroventricular (i.c.v.) injection (10 or 70 microg/kg) at 30 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Control groups received the vehicle only via the same route </plain></SENT>
<SENT sid="6" pm="."><plain>Body temperature was maintained constant, and hemodynamic parameters were monitored during anesthesia </plain></SENT>
<SENT sid="7" pm="."><plain>Laser Doppler flowmetry was used to monitor the regional cerebral blood flow (rCBF) during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion in some rats </plain></SENT>
<SENT sid="8" pm="."><plain>The rats were decapitated on day 3, and their brains were cut into 2-mm thick coronal slices before reaction with a 2% solution of 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> to reveal the <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Compared to the respective control groups, NPY treatment via any method of administration increased the relative <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="10" pm="."><plain>Suppression of rCBF was observed during reperfusion </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that peripheral or central administration of NPY impairs reperfusion following experimental MCAO and worsens the outcome of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>